Large-scale testing (Phase 3)Study completedNCT00793377
What this trial is testing
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer
Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 913